Fasken Martineau DuMoulin advised Ditch Labs on the deal. Ditch Labs announced it has raised C$ 3.25 million (approximately USD$2.43 million) in seed funding to help smokers wean themselves off...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin advised Research Capital Corporation. PyroGenesis Canada Inc. (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY) (“PyroGenesis”) announced that it has closed its previously announced “best-efforts” brokered private placement...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised BULGOLD Inc. in the transaction. BULGOLD Inc. (the “Company”) announced it has closed an approximately C$2.2 million ($1.67 million) non-brokered private placement offering...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Middlefield Limited in the offering. Real Estate Split Corp. (TSX: RS and RS.PR.A) (the “Fund”) announced that it completed an overnight...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Beacon Securities Limited in the transaction. Trigon Metals Inc. announced its brokered private placement offering of 25,000,000 units at a price of...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Steppe Gold Ltd. in the transaction. Steppe Gold Ltd. (“Steppe”) announced that it has completed its acquisition of Anacortes Mining Corp. pursuant...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Middlefield Limited in the transaction. E Split Corp. (TSX: ENS and ENS.PR.A) (the “Fund”) announced that it has completed an overnight public offering...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Debiopharm Innovation Fund in the transaction. Altis Labs Inc. announced the closing of its C$7.9 million ($6 Million) seed funding round co-led by...
You must be a Standard 1 Year member to access this content.
Fasken acted as Canadian counsel to Eldorado on the deal. The European Bank for Reconstruction and Development (“EBRD”) announced a $81.5 Million Strategic Investment in Eldorado.The Concurrent Private...
You must be a Standard 1 Year member to access this content.
Fasken represented Research Capital Corporation in the offering. Algernon Pharmaceuticals Inc. (“Algernon” or “the Company”), a Canadian clinical stage pharmaceutical development company, completed a rights offering...
You must be a Standard 1 Year member to access this content.
Fasken advised First Quantum on the offering. First Quantum Minerals Ltd. announced its upsized offering of US$1.3 billion aggregate principal amount of 8.625% Senior Notes due 2031....
You must be a Standard 1 Year member to access this content.
Fasken advised the Delta Resources, while Cassels acted for the underwriters in the transaction. Delta Resources Limited closed a “bought deal” private placement of (i) 7,143,000...
You must be a Standard 1 Year member to access this content.
